Dr Reddys Laboratories (RDY) Invested Capital (2017 - 2025)
Dr Reddys Laboratories (RDY) has 8 years of Invested Capital data on record, last reported at $3.5 billion in Q1 2024.
- For Q1 2024, Invested Capital fell 4.15% year-over-year to $3.5 billion; the TTM value through Mar 2024 reached $3.5 billion, down 4.15%, while the annual FY2025 figure was $445.0 million, 87.2% down from the prior year.
- Invested Capital reached $3.5 billion in Q1 2024 per RDY's latest filing, down from $3.6 billion in the prior quarter.
- Across five years, Invested Capital topped out at $3.6 billion in Q1 2023 and bottomed at $76.9 million in Q1 2020.
- Average Invested Capital over 5 years is $2.0 billion, with a median of $2.6 billion recorded in 2022.
- Peak YoY movement for Invested Capital: tumbled 79.41% in 2020, then surged 2570.79% in 2022.
- A 5-year view of Invested Capital shows it stood at $76.9 million in 2020, then increased by 27.77% to $98.2 million in 2021, then soared by 2570.79% to $2.6 billion in 2022, then surged by 37.82% to $3.6 billion in 2023, then dropped by 4.15% to $3.5 billion in 2024.
- Per Business Quant database, its latest 3 readings for Invested Capital were $3.5 billion in Q1 2024, $3.6 billion in Q1 2023, and $2.6 billion in Q1 2022.